Summary Abivax S.A. (ABIVAX) is a clinical stage biopharmaceutical company. It focuses on the discovery, development and commercialization of therapeutic vaccines and anti-viral compounds. The company’s technologies are based on RNA-protein interaction Interference, B cell and cytotoxic TH1 cell amplification. ABIVAX’s clinical stage products include ABX203, a vaccine for chronic hepatitis B; and ABX464, a small molecule against HIV. In addition to this, it also offers ABX196, an adjuvant candidate for vaccination which is under phase 1 clinical trial. The company has collaborations with the CIGB, BC Cancer Agency, the CNRS, the Scripps Research Institute, the University of Chicago and the Institut Pasteur, among others. It has research facilities in Evry and Montpellier. ABIVAX is headquartered at Paris, France. Abivax S.A. (ABVX) - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a... Research Beam Model: Research Beam Product ID: 713947 250 USD New
Abivax S.A. (ABVX) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
 
 

Abivax S.A. (ABVX) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • Category : Pharmaceuticals
  • Published On : July   2016
  • Pages : 16
  • Publisher : GlobalData
 
 
 
Summary

Abivax S.A. (ABIVAX) is a clinical stage biopharmaceutical company. It focuses on the discovery, development and commercialization of therapeutic vaccines and anti-viral compounds. The company’s technologies are based on RNA-protein interaction Interference, B cell and cytotoxic TH1 cell amplification. ABIVAX’s clinical stage products include ABX203, a vaccine for chronic hepatitis B; and ABX464, a small molecule against HIV. In addition to this, it also offers ABX196, an adjuvant candidate for vaccination which is under phase 1 clinical trial. The company has collaborations with the CIGB, BC Cancer Agency, the CNRS, the Scripps Research Institute, the University of Chicago and the Institut Pasteur, among others. It has research facilities in Evry and Montpellier. ABIVAX is headquartered at Paris, France.

Abivax S.A. (ABVX) - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals - Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals - Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description - A brief description of the company's operations.
- Key Employees - A list of the key executives of the company.
- Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors - A list of the key competitors of the company.
- Key Recent Developments - A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements
- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy
- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

Table Of Contents
Table of Contents
Table of Contents 2
List of Tables 3
List of Figures 4
Abivax S.A., Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016 5
Abivax S.A., Pharmaceuticals & Healthcare Deals By Type, 2010 to YTD 2016 6
Abivax S.A., Pharmaceuticals & Healthcare, Deals By Region, 2010 to YTD 2016 7
Abivax S.A., Pharmaceuticals & Healthcare, Deals By Therapy Area, 2010 to YTD 2016 8
Abivax S.A., Pharmaceuticals & Healthcare, Deals Summary, 2010 to YTD 2016 9
Abivax S.A., Pharmaceuticals & Healthcare, Deal Details 10
Partnerships 10
ABIVAX Enters into Co-Marketing Agreement with Finlay Institute 10
Licensing Agreements 11
ABIVAX Enters into Licensing Agreement with CIGB for ABX203 11
Equity Offering 12
Abivax Raises USD65 Million in IPO 12
Abivax S.A. - Key Competitors 13
Key Employees 14
Locations And Subsidiaries 15
Head Office 15
Other Locations & Subsidiaries 15
Appendix 16
Methodology 16
About GlobalData 16
Contact Us 16
Disclaimer 16
List Of Tables
List of Tables
Abivax S.A., Pharmaceuticals & Healthcare, Key Facts 1
Abivax S.A., Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016 5
Abivax S.A., Pharmaceuticals & Healthcare Deals By Type, 2010 to YTD 2016 6
Abivax S.A., Pharmaceuticals & Healthcare, Deals By Region, 2010 to YTD 2016 7
Abivax S.A., Deals By Therapy Area, 2010 to YTD 2016 8
Abivax S.A., Pharmaceuticals & Healthcare, Deals Summary, 2010 to YTD 2016 9
ABIVAX Enters into Co-Marketing Agreement with Finlay Institute 10
ABIVAX Enters into Licensing Agreement with CIGB for ABX203 11
Abivax Raises USD65 Million in IPO 12
Abivax S.A., Key Competitors 13
Abivax S.A., Key Employees 14
Abivax S.A., Other Locations 15
Lisst Of Figures
List of Figures
Abivax S.A., Pharmaceuticals & Healthcare, Deals by Type, 2010 to YTD 2016 1
Abivax S.A., Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016 1
Abivax S.A., Pharmaceuticals & Healthcare, Deals By Region, 2010 to YTD 2016 1
Abivax S.A., Pharmaceuticals & Healthcare, Deals By Therapy Area, 2010 to YTD 2016 1
Abivax S.A., Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016 5
Abivax S.A., Pharmaceuticals & Healthcare, Deals by Type, 2010 to YTD 2016 6
Abivax S.A., Pharmaceuticals & Healthcare, Deals By Region, 2010 to YTD 2016 7
Abivax S.A., Pharmaceuticals & Healthcare, Deals By Therapy Area, 2010 to YTD 2016 8
PURCHASE OPTIONS
 
 
 

How can we help you?

Contact us at the Consulting WP office nearest to you or submit a business inquiry online.


  Contact
 

Subscribe to Our Newsletter